alexa
Reach Us +44-1647-403003
Tumor Microenvironment In Breast Cancer Brain Metastases | 33697
ISSN: 1948-5956

Journal of Cancer Science & Therapy
Open Access

Like us on:

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
Share This Page

Tumor microenvironment in breast cancer brain metastases

World Congress on Breast Cancer

Mihaela Lorger

University of Leeds, UK

ScientificTracks Abstracts: J Cancer Sci Ther

DOI: 10.4172/1948-5956.S1.041

Abstract
Brain metastases occur in ~15 % of patients with advanced breast cancer. Their incidence is particularly high in triple negative and HER2-positive disease (30-50%). Therapeutic options for brain metastases are limited and patients with central nervous system involvement have very poor prognosis. In order to better understand the biology of brain metastases, we studied tumour microenvironment in the brain using pre-clinical models of breast cancer brain metastases. In addition to characterizing the inflammatory tumour microenvironment, we developed a pre-clinical strategy for an improved delivery of therapeutic agents into the brain using bone marrow-derived macrophages.
Biography

Mihaela Lorger is a tenure-track group leader at the University of Leeds since 2011. She obtained her PhD degree in biology from the Darmstadt University of Technology, Germany. During her Postdoctoral studies at the University of Zurich in Switzerland and at The Scripps Research Institute in La Jolla USA, she focused on breast cancer progression and metastasis. Her current focus is on the development of cell-based and immune-modulatory therapies for brain metastases.

Relevant Topics
Top